CRISTIAN RODRIGUEZ: Open Payments
NPI 1760760037 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,765 in 95 payments from 23 companies in 2025. Trend: 2023 $478 · 2024 $1,612 · 2025 $1,765
Food & beverage: $1,765
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $254 |
| ABBVIE INC. | 18 | $208 |
| AstraZeneca Pharmaceuticals LP | 7 | $155 |
| Otsuka America Pharmaceutical, Inc. | 11 | $150 |
| GlaxoSmithKline, LLC. | 8 | $136 |
| Lilly USA, LLC | 7 | $127 |
| Lundbeck LLC | 3 | $81 |
| Axsome Therapeutics, Inc. | 3 | $68 |
| Indivior Inc. | 4 | $66 |
| Exact Sciences Corporation | 4 | $60 |
Products named: REXULTI, Wegovy, TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, FARXIGA, AIRSUPRA, Ozempic.
Industry payments across MI — which companies pay providers there.
